Literature DB >> 35958499

A novel mutation of the NF1 gene in a Chinese family with neurofibromatosis type 1.

Qi He1, Jingjing Jiang1, Jiao Yang1, Junjie Zeng2, Huan Zhang1, Zhengzhong Zhang1.   

Abstract

BACKGROUND: Mutations in the neurofibromin 1 (NF1) gene are associated with clinical manifestations of neurofibromatosis type 1 (NF1).
OBJECTIVE: To clarify the relationship between NF1 variants and disease phenotype.
METHODS: Peripheral blood samples were collected from a patient and her relatives and genomic DNA was extracted for next-generation sequencing (NGS) to detect potential variants; the results were validated by Sanger sequencing.
RESULTS: A novel frameshift variant c.4508_c.4509delAT (p.Asn1503fsTer26) was detected in exon 34 of the NF1 gene in the patient and her daughter, but not in any other (healthy) family member. This c.4508_c.4509delAT (p.Asn1503fsTer26) frameshift variant of NF1 may underlie NF1 in this family.
CONCLUSIONS: This finding expands the spectrum of pathogenic mutations of the NF1 gene, which could aid genetic counseling and prenatal diagnosis. AJTR
Copyright © 2022.

Entities:  

Keywords:  NF1 gene; Neurofibromatosis type 1; Sanger sequencing; mutation; whole-exome sequencing

Year:  2022        PMID: 35958499      PMCID: PMC9360891     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  28 in total

1.  The development of cutaneous neurofibromas.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Tom Callens; Elina Jokinen; Anthony M Heape; Ludwine Messiaen; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.

Authors:  Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta
Journal:  Behav Genet       Date:  2020-02-05       Impact factor: 2.805

Review 3.  Neurofibromatosis type 1.

Authors:  David H Gutmann; Rosalie E Ferner; Robert H Listernick; Bruce R Korf; Pamela L Wolters; Kimberly J Johnson
Journal:  Nat Rev Dis Primers       Date:  2017-02-23       Impact factor: 52.329

4.  Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.

Authors:  D G Evans; E Howard; C Giblin; T Clancy; H Spencer; S M Huson; F Lalloo
Journal:  Am J Med Genet A       Date:  2010-02       Impact factor: 2.802

5.  Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.

Authors:  Hilde Brems; Magdalena Chmara; Mourad Sahbatou; Ellen Denayer; Koji Taniguchi; Reiko Kato; Riet Somers; Ludwine Messiaen; Sofie De Schepper; Jean-Pierre Fryns; Jan Cools; Peter Marynen; Gilles Thomas; Akihiko Yoshimura; Eric Legius
Journal:  Nat Genet       Date:  2007-08-19       Impact factor: 38.330

Review 6.  Mutation-Directed Therapeutics for Neurofibromatosis Type I.

Authors:  Andre Leier; David M Bedwell; Ann T Chen; George Dickson; Kim M Keeling; Robert A Kesterson; Bruce R Korf; Tatiana T Marquez Lago; Ulrich F Müller; Linda Popplewell; Jiangbing Zhou; Deeann Wallis
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-29       Impact factor: 8.886

7.  Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

Authors:  Erin Rooney Riggs; Erica F Andersen; Athena M Cherry; Sibel Kantarci; Hutton Kearney; Ankita Patel; Gordana Raca; Deborah I Ritter; Sarah T South; Erik C Thorland; Daniel Pineda-Alvarez; Swaroop Aradhya; Christa Lese Martin
Journal:  Genet Med       Date:  2019-11-06       Impact factor: 8.822

8.  Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation.

Authors:  Magdalena Koczkowska; Tom Callens; Alicia Gomes; Angela Sharp; Yunjia Chen; Alesha D Hicks; Arthur S Aylsworth; Amedeo A Azizi; Donald G Basel; Gary Bellus; Lynne M Bird; Maria A Blazo; Leah W Burke; Ashley Cannon; Felicity Collins; Colette DeFilippo; Ellen Denayer; Maria C Digilio; Shelley K Dills; Laura Dosa; Robert S Greenwood; Cristin Griffis; Punita Gupta; Rachel K Hachen; Concepción Hernández-Chico; Sandra Janssens; Kristi J Jones; Justin T Jordan; Peter Kannu; Bruce R Korf; Andrea M Lewis; Robert H Listernick; Fortunato Lonardo; Maurice J Mahoney; Mayra Martinez Ojeda; Marie T McDonald; Carey McDougall; Nancy Mendelsohn; David T Miller; Mari Mori; Rianne Oostenbrink; Sebastién Perreault; Mary Ella Pierpont; Carmelo Piscopo; Dinel A Pond; Linda M Randolph; Katherine A Rauen; Surya Rednam; S Lane Rutledge; Veronica Saletti; G Bradley Schaefer; Elizabeth K Schorry; Daryl A Scott; Andrea Shugar; Elizabeth Siqveland; Lois J Starr; Ashraf Syed; Pamela L Trapane; Nicole J Ullrich; Emily G Wakefield; Laurence E Walsh; Michael F Wangler; Elaine Zackai; Kathleen B M Claes; Katharina Wimmer; Rick van Minkelen; Alessandro De Luca; Yolanda Martin; Eric Legius; Ludwine M Messiaen
Journal:  Genet Med       Date:  2018-09-07       Impact factor: 8.822

9.  Spinal neurofibromatosis with NF1 mutation in a classic neurofibromatosis type 1 family: A case report and literature review.

Authors:  Zeqian Ning; Zhiqian Yang; Gaofei Chen; Wenjiao Wu; Longshuang He; Yesheng Sun; Dongpeng Cai; Wei Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-11-11       Impact factor: 2.183

10.  Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.

Authors:  Silvia Vannelli; Raffaele Buganza; Federica Runfola; Ilaria Mussinatto; Antonio Andreacchio; Luisa de Sanctis
Journal:  Ital J Pediatr       Date:  2020-05-11       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.